Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by eric40on Sep 21, 2020 9:09am
220 Views
Post# 31590250

RE:RE:RE:NR : FDA accepts LMNL's BLA (Riplazym)

RE:RE:RE:NR : FDA accepts LMNL's BLA (Riplazym)From FDA approval list . I found it 2 years ago when the BLA was rejected for CMC issue. So I search on the FDA site for information about other pharma who had their BLA/NDA rejected for CMC reasons in order to know more about that kind of rejections. 

Their was a list of BLA/NDA approbation after a resubmission with all the details (pharma names, drug names, cmc issues and time between resubmission and approval.

I will try to find it again and post it
<< Previous
Bullboard Posts
Next >>